Literature DB >> 1562656

Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci.

S Handwerger1, D C Perlman, D Altarac, V McAuliffe.   

Abstract

Enterococci are important nosocomial pathogens among which resistance to multiple antibiotics is being recognized with increasing frequency. We characterized three clinical isolates from three New York City hospitals that demonstrated concomitant resistance to vancomycin (one VanA, two VanB phenotypes) and high-level resistance to penicillin. Two Enterococcus faecium strains were intrinsically highly resistant to penicillin and showed very low affinity for penicillin of penicillin-binding protein 5. Unlike previously described glycopeptide-resistant enterococci, these strains were not hypersusceptible to beta-lactam agents after vancomycin induction, and combinations of penicillin and vancomycin were not synergistic against them. A third isolate, Enterococcus faecalis, produced beta-lactamase. Two of the three strains were also highly resistant to all aminoglycosides. Emergence of concomitant high-level resistance to multiple antibiotic classes among enterococci considerably narrows the therapeutic options for treatment of infections due to these opportunistic pathogens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562656     DOI: 10.1093/clinids/14.3.655

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Resistant enterococci--mechanisms, laboratory detection and control in hospitals.

Authors:  J J Wade; A H Uttley
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 5.  Diversity among multidrug-resistant enterococci.

Authors:  B E Murray
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

6.  Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.

Authors:  L Gutmann; S al-Obeid; D Billot-Klein; M L Guerrier; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

Authors:  P French; E Venuti; H S Fraimow
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.

Authors:  N Mobarakai; J M Quale; D Landman
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.

Authors:  M Green; B Binczewski; A W Pasculle; M Edmund; K Barbadora; S Kusne; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

10.  Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit.

Authors:  M A Montecalvo; H Horowitz; C Gedris; C Carbonaro; F C Tenover; A Issah; P Cook; G P Wormser
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.